Lv2
170 积分 2025-07-17 加入
Marked Alteration of Rosuvastatin Pharmacokinetics in Healthy Chinese with ABCG2 34G>A and 421C>A Homozygote or Compound Heterozygote
15天前
已完结
Effects of pharmacogenomics-guided treatment on medication adherence and the antidepressant switching rate in major depressive disorder
25天前
已完结
Low-Density Lipoprotein Cholesterol Time in Target Range and Clinical Outcomes in the General Population
1个月前
已完结
Low-Density Lipoprotein Cholesterol Time in Target Range and Clinical Outcomes in the General Population
1个月前
已完结
Effect of Pharmacogenetic Testing for Statin Myopathy Risk vs Usual Care on Blood Cholesterol
1个月前
已完结
Occurrence rate and risk factors for long‐term central line‐associated bloodstream infections in patients with cancer: A systematic review
2个月前
已完结
SLCO1B1 and ABCB1 variants synergistically influence the atorvastatin treatment response in South Indian coronary artery disease patients
2个月前
已完结
Long-term time in target range for body mass index (BMI) and diabetes incidence: insights from CHARLS
2个月前
已完结
Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin
3个月前
已完结
The SLCO1B1 c.521T>C polymorphism is associated with dose decrease or switching during statin therapy in the Rotterdam Study
3个月前
已完结
皖公网安备34019202002308
